The incidences of postoperative hypoparathyroidism during thyroid surgery with ipsilateral central lymph node dissection for papillary thyroid carcinoma were close to that during thyroid surgery for benign thyroid diseases necessitating surgical intervention: a retrospective study
2024

Postoperative Hypoparathyroidism in Thyroid Surgery for Papillary Thyroid Carcinoma

Sample size: 1232 publication 10 minutes Evidence: moderate

Author Information

Author(s): Wang Bin, Zhu Chun-Rong, Fei Yuan, ShanZhou Qiyue, Liu Hong, Yao Xin-Min, Wu Jian

Primary Institution: The Third People’s Hospital of Chengdu

Hypothesis

Does central lymph node dissection increase the incidence of postoperative hypoparathyroidism during thyroid surgery for papillary thyroid carcinoma compared to surgery for benign thyroid diseases?

Conclusion

The incidence of postoperative hypoparathyroidism during thyroid surgery with central lymph node dissection for papillary thyroid carcinoma is comparable to that during surgery for benign thyroid diseases.

Supporting Evidence

  • The incidence of immediate hypoparathyroidism was 9.2% for benign thyroid diseases and 3.0% for papillary thyroid carcinoma.
  • For total thyroidectomy, the immediate hypoparathyroidism rates were 25.0% for benign and 33.8% for papillary thyroid carcinoma.
  • The study included a total of 1232 patients.

Takeaway

This study looked at how thyroid surgery affects a condition called hypoparathyroidism. It found that the surgery for cancer and non-cancer cases had similar effects on this condition.

Methodology

The study compared postoperative hypoparathyroidism incidence between patients undergoing thyroidectomy with central neck dissection for papillary thyroid carcinoma and those undergoing thyroidectomy for benign thyroid diseases.

Potential Biases

Potential bias due to the retrospective nature of the study and the exclusion criteria.

Limitations

The study is retrospective and may have selection bias.

Participant Demographics

Patients who underwent thyroid surgery between July 2018 and December 2022, including those with papillary thyroid carcinoma and benign thyroid diseases.

Statistical Information

P-Value

P = 0.157; P = 0.06; P = 0.12; P = 0.99

Confidence Interval

95% CI 1.034–3.849

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fendo.2024.1461553

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication